A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

Moreover, innovations in LNP formulations have improved not only their targeting ability, but also their drug-loading ...

BERLIN--(BUSINESS WIRE)--Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

Certest Pharma specializes in advanced lipid nanoparticle technology, focusing on the development of effective and targeted LNPs for next-generation medicines. Certest’s licensable technology includes ...

Massachusetts-based Hopewell Therapeutics closed $25 million in seed funding on June 7. The start-up aims to design lipid nanoparticles (LNPs) for delivering nucleic acid cargos to treat lung diseases ...

Researchers from NUS Medicine have developed a novel RNA-based therapy that could transform treatment for metabolic dysfunction-associated steatohepatitis (MASH), previously known as Non-alcoholic ...

The Korea National Institute of Health, under the Korea Disease Control and Prevention Agency, announced on the 17th that it ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...